Search Results

There are 8581399 results for: content related to: Pegylated interferon and ribavirin: a therapeutic option in patients who fail to respond to telaprevir-based triple therapy?

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  3. Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E163–E171, Hitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, Norio Akuta, Taito Fukushima, Tasuku Hara, Yusuke Kawamura, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 8 JAN 2014, DOI: 10.1111/hepr.12268

  4. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 176–183, Harald Farnik, Tim Zimmermann, Eva Herrmann, Wolf O. Bechstein, Bernd Kronenberger, Peter R. Galle, Sandra Labocha, Nerea Ferreiros, Gerd Geisslinger, Stefan Zeuzem, Christoph Sarrazin and Martin W. Welker

    Version of Record online : 9 APR 2014, DOI: 10.1111/liv.12532

  5. You have full text access to this OnlineOpen article
    Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e112–e119, I. Yamada, F. Suzuki, N. Kamiya, K. Aoki, Y. Sakurai, M. Kano, H. Matsui and H. Kumada

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1365-2893.2011.01514.x

  6. You have free access to this content
    The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 431–439, Varun Garg, Gurudatt Chandorkar, Yijun Yang, Nathalie Adda, Lindsay McNair, Katia Alves, Frances Smith and Rolf P. G. van Heeswijk

    Version of Record online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04345.x

  7. Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 8, August 2015, Pages: 1309–1316, Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, Hideyuki Nomura, Akira Kawano, Kazuhiro Takahashi, Kazufumi Dohmen, Takeaki Satoh, Koichi Azuma, Makoto Nakamuta, Toshimasa Koyanagi, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi and The Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 23 JUL 2015, DOI: 10.1111/jgh.12945

  8. Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma

    Biomedical Chromatography

    Volume 28, Issue 12, December 2014, Pages: 1714–1721, Xinhui Chen, Lane R. Bushman, Kevin J. McAllister, Peter L. Anderson and Jennifer J. Kiser

    Version of Record online : 24 APR 2014, DOI: 10.1002/bmc.3211

  9. Telaprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 951–974, Olga M. Klibanov, Shannon H. Williams, Lisa S. Smith, Jacqueline L. Olin and Stephen B. Vickery

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.10.951

  10. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x

  11. Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions

    Hepatology Research

    Volume 45, Issue 8, August 2015, Pages: 837–845, Goki Suda, Yoshiya Yamamoto, Astushi Nagasaka, Ken Furuya, Mineo Kudo, Yoshimichi Chuganji, Yoko Tsukuda, Seiji Tsunematsu, Fumiyuki Sato, Katsumi Terasita, Masato Nakai, Hiromasa Horimoto, Takuya Sho, Mitsuteru Natsuizaka, Kouji Ogawa, Shunsuke Ohnishi, Makoto Chuma, Yasuyuki Fujita, Riichiro Abe, Miki Taniguchi, Mina Nakagawa, Yasuhiro Asahina, Naoya Sakamoto and for the NORTE Study Group

    Version of Record online : 15 OCT 2014, DOI: 10.1111/hepr.12421

  12. Cocrystalline Solids of Telaprevir with Enhanced Oral Absorption

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 10, October 2015, Pages: 3343–3350, Kathy Stavropoulos, Steven C. Johnston, Yuegang Zhang, Bhisetti Govinda Rao, Michael Hurrey, Patricia Hurter, Elizabeth M. Topp and Irina Kadiyala

    Version of Record online : 11 JUN 2015, DOI: 10.1002/jps.24534

  13. Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial

    The Journal of Clinical Pharmacology

    Volume 54, Issue 5, May 2014, Pages: 563–573, Thomas N. Kakuda, Lorant Leopold, Steven Nijs, Ann Vandevoorde, Herta M. Crauwels, Kirk M. Bertelsen, Marita Stevens, James Witek, Yvon van Delft, Frank Tomaka and Richard M.W. Hoetelmans

    Version of Record online : 3 APR 2014, DOI: 10.1002/jcph.245

  14. Simeprevir or telaprevir with peginterferon and ribavirin for recurrent hepatitis C after living-donor liver transplantation: A Japanese multicenter experience

    Hepatology Research

    Volume 46, Issue 13, December 2016, Pages: 1285–1293, Yoshihide Ueda, Toru Ikegami, Akihiko Soyama, Nobuhisa Akamatsu, Masahiro Shinoda, Kohei Ishiyama, Masaki Honda, Shigeru Marubashi, Hideaki Okajima, Tomoharu Yoshizumi, Susumu Eguchi, Norihiro Kokudo, Yuko Kitagawa, Hideki Ohdan, Yukihiro Inomata, Hiroaki Nagano, Ken Shirabe, Shinji Uemoto and Yoshihiko Maehara

    Version of Record online : 27 MAR 2016, DOI: 10.1111/hepr.12684

  15. You have free access to this content
    Efficacy and safety of telaprevir and boceprevir in patients with hepatitis C genotype 1: a meta-analysis

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 1, February 2014, Pages: 14–24, C. Park, S. Jiang and K. A. Lawson

    Version of Record online : 16 NOV 2013, DOI: 10.1111/jcpt.12106

  16. Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

    Journal of Viral Hepatitis

    Volume 22, Issue 12, December 2015, Pages: 992–1001, E. Ogawa, N. Furusyo, K. Dohmen, E. Kajiwara, A. Kawano, H. Nomura, K. Takahashi, T. Satoh, K. Azuma, M. Nakamuta, T. Koyanagi, K. Kotoh, S. Shimoda, J. Hayashi and The Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 15 JUN 2015, DOI: 10.1111/jvh.12427

  17. You have free access to this content
    Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 1, January 2014, Pages: 93–103, L. I. Backus, P. S. Belperio, T. A. Shahoumian, R. Cheung and L. A. Mole

    Version of Record online : 10 NOV 2013, DOI: 10.1111/apt.12546

  18. You have free access to this content
    Optimal treatment with telaprevir for chronic HCV infection

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 3–13, Arun B. Jesudian and Ira M. Jacobson

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12079

  19. The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir

    The Journal of Clinical Pharmacology

    Volume 52, Issue 10, October 2012, Pages: 1574–1583, Dr Varun Garg, Dr Rolf van Heeswijk, Dr Yijun Yang, Dr Robert Kauffman, Dr Frances Smith and Dr Nathalie Adda

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011419855

  20. Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 144–150, Akihito Tsubota, Noritomo Shimada, Masanori Atsukawa, Hiroshi Abe, Keizo Kato, Makiko Ika, Hiroshi Matsudaira, Keisuke Nagatsuma, Tomokazu Matsuura and Yoshio Aizawa

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jgh.12402